Download PDF BrochureInquire Before Buying
The South Korea Image-Guided Radiation Therapy (IGRT) Market focuses on super advanced cancer treatment where doctors use real-time imaging (like X-rays or CT scans taken right before or during treatment) to precisely target tumors while minimizing damage to healthy surrounding tissue. This is a big deal in South Korean hospitals because it allows for incredibly accurate radiation delivery, making treatments faster and more effective, especially for moving tumors, and it represents a major push toward adopting the latest high-tech equipment in oncology care.
The Image-Guided Radiation Therapy Market in South Korea is estimated at US$ XX billion in 2024-2025 and is projected to reach US$ XX billion by 2030, growing steadily at a CAGR of XX%.
The global image-guided radiation therapy market was valued at $1.8 billion in 2022, increased to $1.9 billion in 2023, and is expected to reach $2.4 billion by 2028, growing at a robust 5.2% CAGR.
Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171554723
Drivers
The South Korea Image-Guided Radiation Therapy (IGRT) market is experiencing robust growth, primarily propelled by the nation’s high cancer incidence rates and a sophisticated, technology-friendly healthcare system. Cancer has been a leading cause of death in Korea for decades, and the demand for highly precise and effective treatment modalities like IGRT is accelerating. IGRT ensures accuracy by using real-time or near real-time imaging (such as CBCT, MRI, or X-ray fluoroscopy) to localize tumors before and during each radiation fraction, which is crucial for treating mobile tumors (e.g., in the lungs or prostate) and reducing margins around the target. Strong government investment and widespread access to advanced medical technology, often covered by the National Health Insurance Service (NHIS), facilitate the rapid adoption of expensive, state-of-the-art IGRT systems, including those that integrate Magnetic Resonance Imaging (MRI), such as the world’s first MR Image-Guided Radiation Therapy system installed in Korea. Furthermore, the increasing specialization of oncology centers and the emphasis on improving patient outcomes through reduced side effects drive the utilization of IGRT, particularly for complex treatments like Stereotactic Body Radiation Therapy (SBRT), where extreme accuracy is essential. The push for personalized medicine further solidifies IGRT’s role, as it allows for adaptive radiotherapy, adjusting treatment plans based on real-time anatomical changes.
Restraints
Despite strong drivers, the South Korean IGRT market faces certain restraints, most notably the high capital investment required for purchasing and maintaining advanced IGRT equipment. Systems combining MR imaging or high-end linear accelerators are extremely costly, posing a significant financial hurdle, especially for smaller or rural hospitals. The need for highly specialized technical expertise represents another major constraint; operating and maintaining sophisticated IGRT technology requires physicists, dosimetrists, and radiation oncologists with advanced training in image registration, contouring, and adaptive planning. A lack of sufficient reimbursement rates or complex reimbursement policies from the National Health Insurance Service (NHIS) for certain high-precision IGRT procedures can also limit wider adoption across all patient groups or healthcare facilities. Furthermore, the clinical workflow associated with IGRT is considerably more complex and time-consuming than conventional radiation therapy, requiring extended treatment slots and potentially reducing patient throughput. Finally, while technological integration is high, challenges exist in ensuring seamless data transfer and interoperability between disparate imaging systems (CT, MRI, PET) and the planning/delivery systems, which can complicate the adaptive planning process.
Opportunities
Significant opportunities exist for growth in the South Korean IGRT market, particularly through the expansion of MR-guided radiation therapy (MRgRT). As demonstrated by the installation of the world’s first MR-guided system in Korea, the market is positioned to lead in the adoption of this technology, which offers superior soft-tissue visualization and the potential for real-time dose adaptation. Another major opportunity lies in expanding IGRT applications to non-oncology areas, such as using high-precision radiation delivery for certain benign conditions or palliative care, maximizing the return on investment for existing equipment. The push toward decentralized oncology services creates an opportunity for developing compact and more affordable IGRT systems suitable for smaller clinics or regional centers. Furthermore, there is a clear chance to integrate domestic ICT (Information and Communication Technology) expertise to develop local, customized software for treatment planning, image fusion, and quality assurance, reducing reliance on expensive foreign vendors. Finally, the rise of stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS) as preferred treatment methods for early-stage or metastatic cancers strongly supports IGRT market expansion, as these high-dose, few-fraction techniques critically depend on sub-millimeter accuracy provided only by IGRT.
Challenges
Key challenges confronting the South Korean IGRT market revolve around standardization, quality control, and widespread clinical evidence validation. Ensuring consistency and quality assurance across various IGRT platforms and clinical sites remains a complex task, as IGRT relies heavily on the technical proficiency of the operational team and the calibration of multiple integrated systems. Tumor motion management, particularly in the lung and abdomen, presents a technical challenge requiring sophisticated four-dimensional imaging and gating techniques to maintain accuracy during beam delivery. Furthermore, while IGRT offers high precision, robust, long-term clinical data is continuously required to demonstrate superior survival benefits and cost-effectiveness compared to established conventional radiotherapy, especially for newly introduced IGRT modalities. Overcoming the initial resistance to change among some clinical staff, who are accustomed to simpler workflows, requires ongoing education and training. Lastly, managing and storing the massive volume of high-resolution image data generated by daily IGRT procedures requires significant investment in hospital IT infrastructure, cloud computing, and cybersecurity measures to comply with patient data protection laws.
Role of AI
Artificial Intelligence (AI) is rapidly becoming an indispensable component of the South Korean IGRT market, playing a critical role in enhancing efficiency and precision. AI algorithms are being deployed to automate and significantly accelerate the most time-consuming aspects of IGRT planning and delivery. This includes AI-driven auto-contouring, which uses machine learning to quickly and accurately delineate tumors and organs-at-risk on daily verification images, dramatically reducing the preparation time for adaptive radiotherapy. Moreover, AI is central to motion management, predicting and tracking respiratory or cardiac motion in real-time to adjust the radiation beam dynamically, ensuring the dose is always delivered precisely to the target. Machine learning models can also be used for treatment optimization, rapidly calculating and selecting the best treatment plan among multiple possibilities based on daily anatomical variations, facilitating true adaptive therapy. In quality assurance, AI automates the analysis of large patient datasets to detect subtle errors or deviations from the planned treatment, improving overall safety and reliability, allowing researchers and clinicians in South Korea to fully leverage IGRT capabilities.
Latest Trends
Several cutting-edge trends are defining the trajectory of the South Korean IGRT market. One prominent trend is the adoption of hybrid IGRT systems, particularly MR-Linacs, which combine the high-resolution soft-tissue imaging capability of MRI with high-energy radiation delivery in a single platform. This technology enables superior visualization of tumors and surrounding healthy tissue, supporting true real-time adaptive radiotherapy (ART) where the treatment plan is recalculated and optimized during the treatment session. Another key trend is the development and increasing use of surface-guided radiation therapy (SGRT), which employs advanced optical tracking systems to monitor the patient’s external surface position continuously without the need for implanted fiducial markers or additional radiation exposure, improving patient setup accuracy and workflow efficiency. Furthermore, there is a growing focus on integrating IGRT with advanced treatment delivery techniques like proton therapy and heavy ion therapy, leveraging IGRT’s precision to maximize the dose deposition in these highly conformal treatments. Finally, the development of integrated digital platforms that consolidate treatment planning, imaging data, and delivery logs is trending, aiming to create a seamless, end-to-end digital oncology ecosystem across South Korean hospitals.
Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171554723